drugset / Trial / NCT00830154
A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering
Phase 2/3
Completed
321 enrolled
Endo USA Inc., a Keenova Therapeutics Company
Teva Pharmaceuticals USA · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A multicenter, randomized, 3 arm, placebo-controlled clinical trial to assess the efficacy, safety and tolerability of pagoclone for adults with stuttering.
Timeline
- Start
- 2009-02
- Primary completion
- 2010-01
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pagoclone | Small molecule | 0.3 mg | — |
| Subject | Pagoclone | Small molecule | 0.6 mg | — |